PROVIDENCE, RI (KAIT) - Doctors in Rhode Island hope to slow or even halt the progression of Alzheimer’s disease through a new experimental treatment.
Dr. Jonathan Drake, associate director of the Alzheimer’s Disease and Memory Disorders Center, has begun targeting a protein in the brain known as TAU for treatment of the disease.
For this TAU study called TANGO, you must have mild memory impairment and be on stable medication.
“It has the potential to be disease-modifying and what I mean by that is many of the medications, or all of the medications we currently have, they help with the symptoms, they boost up brain activity, but they unfortunately don’t affect the overall pathological process that’s driving the disease,” said Drake.
In this study, participants use a new drug which is similar to the one being used to treat another neuro-degenerative disease, ALS.
Doctors will soon begin another trial that will focus on targeting blood vessels in the brain.